LEIDEN JEFFREY M sold VRTX

November 13, 2025 · Form 4 insider transaction

LEIDEN JEFFREY M sold 1,160 shares of Vertex Pharmaceuticals Incorporated at $441.05 per share, a transaction worth $511.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
1,160
Price
$441.05
Total value
$511.6K
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 13, 2025
Filing dateNovember 17, 2025
Shares owned after24,026
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1, which was entered into on 8/6/2025.; Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.; Open market sales reported on this line occurred at a weighted average price of $441.05 (range $441.00 to $441.10).

View the original Form 4 on SEC EDGAR